Under review

1 source with this status, each checked with the publisher on the date shown.

Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49) National Institute for Health and Care Excellence · 2016-07-06 · Tier 1
Under review — checked with the publisher on 2026-09-01 · 1 claim